Frontlight ResearchEarly access
Trial site
Sichuan Cancer Hospital and Research Institute
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Gastric and oesophageal cancer3 trials
- Liver and biliary tract cancer2 trials
- Phase
- Phase 23 trials
- Phase 32 trials
- Status
- Active, not recruiting3 trials
- Not yet recruiting3 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Sichuan Cancer Hospital and Research Institute5 trials
- Sun Yat-sen University2 trials
- Guangzhou University of Traditional Chinese Medicine1 trial
- Guohui Xu1 trial
- Yongtao Han1 trial
Running trials
Not yet recruiting
Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC
Not yet recruiting
Recruiting
TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma
Active, not recruiting
Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Gastric and oesophageal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026